Help Your Patients Afford Their Lenalidomide Therapy
As a pharmacist, you know the conversation well: a patient arrives with a prescription for Lenalidomide Capsules, checks their copay … and the number stops them cold.
Even with commercial insurance, out-of-pocket costs for specialty oncology medications can reach hundreds—sometimes thousands—of dollars per fill. For patients managing multiple myeloma or other serious conditions, that’s not just a financial burden. It’s a barrier to the treatment they need.
Eligible patients pay as little as $0* for Padagis’ Lenalidomide Capsules
*Commercially insured patients pay as little as $0, up to $250 off per fill for Padagis’ Lenalidomide Capsules. Please see full Terms and Conditions for additional details.
About Lenalidomide Capsules
Padagis’ Lenalidomide Capsules (AB-rated generic to Revlimid®) is a prescription medicine, used to treat adults with multiple myeloma (MM) in combination with the medicine dexamethasone, or as maintenance treatment after autologous hematopoietic stem cell transplantation (a type of stem cell transplant that uses your own stem cells). Lenalidomide should not be used to treat people who have chronic lymphocytic leukemia (CLL) unless they are participants in a controlled clinical trial. It is not known if lenalidomide is safe and effective in children.¹ See Full Prescribing Information, including Boxed WARNING and Medication Guide >
Lenalidomide Capsules Product Profile
Therapeutic Equivalency Rating: AB
Generic to: Revlimid®
Product Form: Capsule
| Image | Strength | Imprint Code | Description | Rating | Capsules/Bottle | NDC |
|---|---|---|---|---|---|---|
 | 2.5 mg | NAT-cap; 2.5mg-body | White | AB | 28 | 0574-1402-28 |
 | 5 mg | NAT-cap; 5mg-body | White | AB | 28 | 0574-1405-28 |
 | 10 mg | NAT-cap; 10mg-body | White | AB | 28 | 0574-1410-28 |
 | 15 mg | NAT-cap; 15mg-body | White | AB | 21 | 0574-1415-21 |
 | 20 mg | NAT-cap; 20mg-body | White | AB | 21 | 0574-1420-21 |
 | 25 mg | NAT-cap; 25mg-body | White | AB | 21 | 0574-1425-21 |
Additional resources:
References:
-
Lenalidomide [prescribing information]. Allegan, MI: Padagis US LLC., 2026
Revlimid® is a registered trademark of Celgene Corporation.
